Mapping the Terrain
Elevation Oncology supports a future in which all patients with cancer have access to tests that reveal their tumor’s unique genomic fingerprint.
Surveying the Peaks
In partnership with academic and clinical collaborators and diagnostic leaders, Elevation Oncology actively evaluates emerging genomic research for true oncogenic driver alterations with a druggable pathway.
Blazing the Path
Elevation Oncology continually pursues innovations for more efficient and selective drug development in rare, genomically defined patient populations.
Our Current Treks
Elevation Oncology applies all of its insights towards the development of targeted therapies for novel driver alterations with high unmet patient needs.